Insulin-Like Growth Factor-Binding Protein 3 Induces Caspase-Dependent Apoptosis through a Death Receptor-Mediated Pathway in MCF-7 Human Breast Cancer Cells

Abstract

Insulin-like growth factor-binding protein (IGFBP)-3 has been shown to potently inhibit cell proliferation in various cell systems. However, the specific mechanisms involved in the antiproliferative action of IGFBP-3 have yet to be elucidated. In the present study, we demonstrate that IGFBP-3 induces apoptosis in an insulin-like growth factor (IGF)-independent manner through the activation of caspases involved in a death receptor-mediated pathway in MCF-7 human breast cancer cells. Induction of IGFBP-3 using an ecdysone-inducible expression system inhibited DNA synthesis in an IGF-IGF receptor axis-independent fashion and resulted in the subsequent induction of apoptosis and an increase in caspase activity. Similar results were obtained when cells were transfected with GGG-IGFBP-3, an IGFBP-3 mutant unable to bind IGFs, corroborating the IGF-independent action of IGFBP-3. Additional caspase activity studies and immunoblot analyses using specific caspase substrates and/or caspase inhibitors revealed that the growth-inhibitory effect of IGFBP-3 results mainly from its induction of apoptosis (in particular, activation of caspase-8 and -7). Analyses of caspase-9 activity and release of cytochrome c into the cytosol confirmed that the mitochondria-mediated pathway is not involved. Taken together, these results show that IGFBP-3 expression leads to the induction of apoptosis through the activation of caspases involved in a death receptor-mediated pathway and that IGFBP-3 functions as a negative regulator of breast cancer cell growth, independent of the IGF-IGF receptor axis.

The Therapeutic Potential of Pomegranate and Its Products for Prevention of Cancer

“…In a study, Koyama et al (2010) investigated the relationship between pomegranate-induced apoptosis in human prostate cancer cells and the insuline-like growth factor (IGF)/IGF binding protein (IGFBP) system, as the IGF axis is critical for the regulation of apoptosis in many human cancer cell lines and IGFBPs in serum are responsible for regulation of IGF action, inhibition of cell proliferation and enhancement of apoptosis in many cell types, including prostate (Rajah et al, 1997) and breast (Gucev et al, 1996;Kim et al, 2004) cancers. They concluded that there are novel interactions between the IGF system and pomegranateinduced apoptosis, and pomegranate products modulate the tumor production and responsiveness to IGFs and the IGFBPs.…”

β-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosis

“…DNA fragmentation is a marker and characteristic event of apoptosis (38). An ELISA-based assay performed with mouse monoclonal antibodies directed against DNA and histones provides a quantitative in vitro determination of histone-associated DNA fragments (38,39).…”

Elevated serum insulin-like growth factor binding protein-2 is associated with a high relapse risk after hematopoietic stem cell transplantation in childhood AML

“…7,8 Insulinlike growth factors (IGFs)-I and -II are structurally related polypeptides, which play an important role in cellular proliferation, differentiation and apoptosis. 9,10 They are regulated by a family of binding proteins (IGFBPs), of which six have been identified. 11 The IGFBPs modulate the biological action of IGF-I and IGF-II.…”